首页> 外文期刊>The journal of clinical endocrinology and metabolism >Osteoclastic Metabolism of 25(OH)-Vitamin D3: A Potential Mechanism for Optimization of Bone Resorption
【24h】

Osteoclastic Metabolism of 25(OH)-Vitamin D3: A Potential Mechanism for Optimization of Bone Resorption

机译:25(OH)-维生素D3的破骨代谢:优化骨吸收的潜在机制

获取原文
       

摘要

The extrarenal synthesis of 1 ? ,25 dihydroxyvitamin D 3 (1,25D)has been demonstrated in a number of cell types including os-teoblasts and cells of the monocyte/macrophage lineage. Theskeleton appears responsive to serum levels of the 1,25D pre-cursor, 25 hydroxyvitamin D 3 (25D), in terms of bone mineral-ization parameters. The effect of metabolism of 25D into active1,25D by osteoclast lineage cells is unknown. We found thatCYP27B1 mRNA expression increased with exposure of humanperipheralbloodmononuclearcells(PBMCs)tomacrophagecol-ony-stimulating factor in the presence or absence of receptoractivator of nuclear factor- ? B ligand. Consistent with this, hu-man osteoclast cultures incubated with 25D produced measur-able quantities of 1,25D.
机译:肾外合成1?在许多细胞类型(包括成骨细胞和单核细胞/巨噬细胞谱系的细胞)中已证明了25,25二羟基维生素D 3(1,25D)。就骨骼矿化参数而言,骨骼似乎对1,25D前体25羟基维生素D 3(25D)的血清水平有反应。破骨细胞谱系细胞将25D代谢为active1,25D的作用尚不清楚。我们发现CYP27B1 mRNA表达随人外周血单核细胞(PBMCs)的表达而增加。 B配体。与此相一致,人类破骨细胞培养物与25D孵育产生的可测量量为1,25D。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号